Skip to main content
Equibles

Man Group plc

Position in TGTX — Tg Therapeutics, Inc.

CIK 1637460 LONDON, X0
Back to TGTX Full portfolio

Position in TGTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,272,737
-$4,510,297 QoQ
Shares Held
132,376
-62.7% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#82
of 426 holders
Holding Since
Jun 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TGTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Man Group plc holds $1,100,351,284 across 114 Biotechnology names. TGTX ranks #19 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 436,956 $272,459,544
2 INCY
Incyte Corp
 952,941 $108,025,391
3 ONC
BeOne Medicines Ltd.
 307,463 $87,617,731
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 139,233 $69,161,207
5 APGE
Apogee Therapeutics, Inc.
 397,000 $52,693,809
6 ALNY
Alnylam Pharmaceuticals, Inc.
 170,907 $51,448,133
7 JAZZ
Jazz Pharmaceuticals plc
 152,877 $36,838,770
8 RVMD
Revolution Medicines, Inc.
 173,439 $32,481,655

All Filings in TGTX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,272,737 132,376
2026-03-31 $11,783,034 354,697
2025-12-31 $28,517,348 956,637
2025-09-30 $36,430,689 1,008,462
2025-06-30 $5,030,142 139,765
2024-12-31 $288,628 9,589
2023-06-30 $17,120,621 689,236
2022-12-31 $215,306 18,200
2022-09-30 $192,678 32,547
2022-06-30 $500,000 117,698
2021-09-30 $2,236,282 67,196
2021-06-30 $3,457,081 89,123
2021-03-31 $4,938,331 102,455
2020-12-31 $10,687,404 205,448
2020-09-30 $5,621,847 210,084
2020-06-30 $9,176,813 471,089